Cumberland Partners LTD Merck & Co., Inc. Transaction History

Cumberland Partners LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $7.79 Million - $8.84 Million	-93,360 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $1.01 Million - $1.14 Million	-13,805 Reduced 12.88%	93,360 $7.66 Million
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $738,701 - $925,318	-10,220 Reduced 8.71%	107,165 $8.21 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $45,516 - $50,057	-635 Reduced 0.54%	117,385 $8.82 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $58,708 - $64,937	-835 Reduced 0.7%	118,020 $9.18 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $8.18 Million - $9.64 Million	118,855 New	118,855 $9.16 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $36,594 - $39,889	-481 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$69.84 - $81.59 $33,593 - $39,244	481 New	481 $40,000
Q3 2018 Nov 15, 2018	SELL	$57.69 - $67.84 $201,915 - $237,440	-3,500 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$50.83 - $59.72 $177,905 - $209,020	3,500 New	3,500 $212,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.